Eagle Asset Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-14,861
Closed -$310K 582
2023
Q4
$310K Sell
14,861
-551
-4% -$10.6K ﹤0.01% 533
2023
Q3
$332K Buy
+15,412
New +$374K ﹤0.01% 513
2020
Q4
Sell
-8,328
Closed -$353K 607
2020
Q3
$353K Sell
8,328
-357
-4% -$15.4K ﹤0.01% 526
2020
Q2
$372K Sell
8,685
-119
-1% -$4.7K ﹤0.01% 529
2020
Q1
$288K Sell
8,804
-450
-5% -$16.7K ﹤0.01% 581
2019
Q4
$340K Buy
9,254
+551
+6% +$19.5K ﹤0.01% 611
2019
Q3
$292K Buy
8,703
+22
+0.3% +$780 ﹤0.01% 607
2019
Q2
$340K Buy
+8,681
New +$344K ﹤0.01% 608
2017
Q2
Sell
-8,146
Closed -$343K 646
2017
Q1
$343K Buy
8,146
+1,254
+18% +$51.8K ﹤0.01% 611
2016
Q4
$290K Buy
6,892
+789
+13% +$32.2K ﹤0.01% 608
2016
Q3
$267K Buy
6,103
+9
+0.1% +$403 ﹤0.01% 611
2016
Q2
$265K Hold
6,094
﹤0.01% 610
2016
Q1
$268K Buy
+6,094
New +$258K ﹤0.01% 603

Other funds holding FMS

Eagle Asset Management's FMS Position: Q1 2024 in Review

Eagle Asset Management sold out of Fresenius Medical Care (FMS) in Q1 2024, closing a stake of 14,861 shares — an estimated $310K sold.

Eagle Asset Management first reported a position in FMS in Q1 2016 and held it in 13 quarters. The position peaked at $372K in Q2 2020. 172 funds tracked by Wall St. Rank hold FMS as of Q1 2024.

  • Eagle Asset Management reported no remaining Fresenius Medical Care position as of Q1 2024 after selling out during the quarter.
  • Eagle Asset Management sold 14,861 Fresenius Medical Care shares in Q1 2024, an estimated $310K.
  • Eagle Asset Management first reported a position in Fresenius Medical Care in Q1 2016 and held it in 13 quarters.
  • Eagle Asset Management's Fresenius Medical Care position peaked at $372K in Q2 2020.
  • 172 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2024.

Based on Eagle Asset Management's 13F filing for Q1 2024, filed 9 May 2024.